Paediatric Respiratory Reviews
Volume 4, Issue 1 , Pages 2-8 , March 2003

Approaches to the initial respiratory management of preterm neonates

  • Michael S Dunn

      Affiliations

    • Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada
    • Department of Newborn and Developmental Paediatrics, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada
    • Corresponding Author InformationCorrespondence to: Michael S. Dunn. Tel.: +1-416-323-7312
    • ,
  • Maureen Charlotte Reilly

      Affiliations

    • Department of Newborn and Developmental Paediatrics, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada

References 

  1. Horbar JD, Badger GJ, Carpenter JH, et al.  Trends in mortality and morbidity for very low birth weight infants, 1991–1999. Pediatrics. 2002;110:143–151
  2. Davis JM, Dunn MS. Pharmacologic approaches to the therapy of chronic lung disease in the newborn. Semin. Neonatol. 1998;3:113–118
  3. O’Brodovich HM, Mellins RB. Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury. Am. Rev. Respir. Dis. 1985;132:694–709
  4. Nilsson R, Grossman G, Robertson B. Lung surfactant and the pathogenesis of neonatal bronchiolar lesions induced by artificial ventilation. Pediatr. Res. 1978;12:249–255
  5. Delivoria-Papadopoulos M, Levinson H, Swyer PR. Intermittent positive pressure respiration as a treatment in severe respiratory distress syndrome. Arch. Dis. Child. 1965;40:474–479
  6. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N. Engl. J. Med. 1967;276:357–368
  7. Drew H. Immediate intubation at birth of the very-low-birth-weight infant. Am. J. Dis. Child. 1982;38:207–210
  8. Barrington KJ, Finer NN, Etches PC. Succinylcholine and atropine for premedication of the newborn infant before nasotracheal intubation: a randomized, controlled trial. Crit. Care Med. 1989;17:1293–1296
  9. Bjorklund LJ, Ingimarsson J, Curstedt T, et al.  Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr. Res. 1997;42:348–355
  10. Wiswell TE, Braziani LJ, Kornhauser MS, et al.  Effects of hypocarbia on the development of cystic periventricular leukomalacia in premature infants treated with high-frequency jet ventilation. Pediatrics. 1996;98:918–924
  11. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am. J. Dis. Child. 1959;97:517–523
  12. Soll RF, McQueen MC. Respiratory distress syndrome. In: Sinclair JC and Bracken MB. Effective Care of the Newborn. Oxford: Oxford University Press, 1992; 325–358.
  13. Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet. 1980;i:55–59
  14. Smyth JA, Metcalfe IL, Duffty P, Possmayer F, Bryan MH, Enhorning G. Hyaline membrane disease treated with bovine surfactant. Pediatrics. 1983;71:913–917
  15. Enhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics. 1985;76:145–153
  16. Walther FJ, Kuipers IM, Gidding CE, Willebrand D, Buchholtz RT, Bevers EM. A comparison of high-frequency oscillation superimposed onto backup mechanical ventilation and conventional mechanical ventilation on the distribution of exogenous surfactant in premature lambs. Pediatr. Res. 1987;22:725–729
  17. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants (Cochrane review). In: The Cochrane Library, issue 1, 2001. Oxford: Update Software.
  18. Dunn MS. Surfactant replacement therapy prophylaxis or treatment?. Pediatrics. 1993;92:148–150
  19. Poets CF, Sens B. Changes in intubation rates and outcome of very low birth weight infants: a population-based study. Pediatrics. 1996;98:24–27
  20. Sahni R, Wung JT. Continuous positive airway pressure (CPAP). Indian J. Pediatr. 1998;65:265–271
  21. Avery ME, Tooley WH, Keller JB, et al.  Is chronic lung disease in low birth weight infants preventable? A survey of eight centres. Pediatrics. 1987;79:26–30
  22. Gregory A, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N. Engl. J. Med. 1971;284:1333–1340
  23. Jacobson T, Gronvall J, Petersen S, Andersen GE. Minitouch treatment of very low-birth-weight infants. Acta Paediatr. 1993;82:934–938
  24. Kamper J, Wulff K, Larsen C, Lindquist S. Early treatment with nasal continuous positive airway pressure in very low birth weight infants. Acta Paediatr. 1993;82:193–197
  25. Gitterman MK, Fusch C, Gitterman AR, Regazzoni BM, Moessinger AC. Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low weight infants. Eur. J. Pediatr. 1997;156:384–388
  26. Lindner W, Voßbeck S, Hummler H, Pohlandt F. Delivery room management of extremely low birth weight infants: spontaneous breathing or intubation. Pediatrics. 1999;103:961–967
  27. De Klerk AM, De Klerk RK. Nasal continuous positive airway pressure and outcomes of preterm infants. J. Paediatr. Child Health. 2001;37:161–167
  28. Verder H, Robertson B, Greisen G, et al.  Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N. Engl. J. Med. 1994;331:1051–1055
  29. Verder H, Albertsen P, Ebbesen F, et al.  Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks gestation. Pediatrics. 1999;103:e24
  30. Soll RF, Yost CC. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome (Cochrane review). In: The Cochrane Library, issue 2, 2000. Oxford: Update Software.
  31. Thomson MA. IFDAS Study Group. Early nasal continuous positive airway pressure (nCPAP) with prophylactic surfactant for neonates at risk of RDS. The IFDAS Multi-Centre Randomised Trial. Pediatr. Res. 2002;51:379A

PII: S1526-0542(02)00305-6

doi: 10.1016/S1526-0542(02)00305-6

Paediatric Respiratory Reviews
Volume 4, Issue 1 , Pages 2-8 , March 2003

Article Tools